Correlation Between Biotechnology Portfolio and Advent Claymore
Can any of the company-specific risk be diversified away by investing in both Biotechnology Portfolio and Advent Claymore at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Portfolio and Advent Claymore into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Portfolio Biotechnology and Advent Claymore Convertible, you can compare the effects of market volatilities on Biotechnology Portfolio and Advent Claymore and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Portfolio with a short position of Advent Claymore. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Portfolio and Advent Claymore.
Diversification Opportunities for Biotechnology Portfolio and Advent Claymore
0.92 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Biotechnology and Advent is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Portfolio Biotec and Advent Claymore Convertible in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Advent Claymore Conv and Biotechnology Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Portfolio Biotechnology are associated (or correlated) with Advent Claymore. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Advent Claymore Conv has no effect on the direction of Biotechnology Portfolio i.e., Biotechnology Portfolio and Advent Claymore go up and down completely randomly.
Pair Corralation between Biotechnology Portfolio and Advent Claymore
Assuming the 90 days horizon Biotechnology Portfolio Biotechnology is expected to generate 1.88 times more return on investment than Advent Claymore. However, Biotechnology Portfolio is 1.88 times more volatile than Advent Claymore Convertible. It trades about 0.24 of its potential returns per unit of risk. Advent Claymore Convertible is currently generating about 0.27 per unit of risk. If you would invest 1,748 in Biotechnology Portfolio Biotechnology on May 27, 2025 and sell it today you would earn a total of 316.00 from holding Biotechnology Portfolio Biotechnology or generate 18.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biotechnology Portfolio Biotec vs. Advent Claymore Convertible
Performance |
| Timeline |
| Biotechnology Portfolio |
| Advent Claymore Conv |
Biotechnology Portfolio and Advent Claymore Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biotechnology Portfolio and Advent Claymore
The main advantage of trading using opposite Biotechnology Portfolio and Advent Claymore positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Portfolio position performs unexpectedly, Advent Claymore can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Advent Claymore will offset losses from the drop in Advent Claymore's long position.The idea behind Biotechnology Portfolio Biotechnology and Advent Claymore Convertible pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Advent Claymore vs. Nuveen Real Asset | Advent Claymore vs. Guggenheim Active Allocation | Advent Claymore vs. DWS Municipal Income | Advent Claymore vs. Guggenheim Taxable Municipal |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |